Evidence map›Paper›PMID 36946132›Full record

ArticleBiology letters2023

Systemic orchestration of cell size throughout the body: influence of sex and rapamycin exposure in

Ewa Szlachcic, Anna Maria Labecka, Valeriya Privalova, Anna Sikorska, Marcin Czarnoleski

Open access · hybridFull text read
In one paragraph

Article in Biology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Heat tolerance inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  3. Rapamycin supplementation ofRoyal Society open science · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ewa SzlachcicLife History Evolution Group, Institute of Environmental Sciences, Faculty of Biology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.ORCID 0000-0002-4179-4068
Anna Maria LabeckaLife History Evolution Group, Institute of Environmental Sciences, Faculty of Biology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.ORCID 0000-0002-8810-7093
Valeriya PrivalovaLife History Evolution Group, Institute of Environmental Sciences, Faculty of Biology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.ORCID 0000-0002-8496-7352
Anna SikorskaLife History Evolution Group, Institute of Environmental Sciences, Faculty of Biology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.ORCID 0000-0003-1668-2264
Marcin CzarnoleskiLife History Evolution Group, Institute of Environmental Sciences, Faculty of Biology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.ORCID 0000-0003-2645-0360
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Along with differences in life histories, metazoans have also evolved vast differences in cellularity, involving changes in the molecular pathways controlling the cell cycle. The extent to which the signalling network systemically determines cellular composition throughout the body and whether tissue cellularity is organized locally to match tissue-specific functions are unclear. We cultured genetic lines of

Indexed as

Drosophila ProteinsInsulinsAnimalsBody SizeCell SizeDrosophila melanogasterFemaleMaleSirolimusTOR Serine-Threonine KinasesDrosophila ProteinsInsulinsSirolimusTOR Serine-Threonine Kinasesbody sizecell sizeDrosophila melanogastersignalling pathwaystarget of rapamycin

Identifiers

PMID36946132
PMCPMC10031402
OpenAlexW4353020327

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read28
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.